bridge4

September 17 – 19, 2017

San Diego, California
* Visit us at Booth #302
Dr. Kenneth Lasseter has authored a poster titled “An Open Label, Single Dose, Phase 1 Study of the Pharmacokinetics and Safety of JZP110 in Subjects With Normal or Impaired Renal Function and With End Stage Renal Disease Requiring Hemodialysis” to be presented during Session 1 on September 17th, 5:30pm – 7:30am and Session 2 Monday, September 18th 8am – 10am

October 5 – 8, 2017

Boca Raton, Florida

November 2 – 4, 2017

Boston, Massachusetts

November 16 – 19, 2017

Boca Raton, Florida

View Our Network of Clinical Research Sites